Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nerve sheath neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neurofibroma, neurofibromatosis, neurofibromatosis type 1, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, plexiform neurofibromaRecruitingPhase 22026-05-29NCT06188741

3 results · Page 1 of 1

Swipe the table sideways for more columns.

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Boston Children's HospitalBostonUnited States343
Children's Hospital of Los AngelesLos AngelesUnited States56
Children's Hospital of PhiladelphiaPhiladelphiaUnited States434
Children's National HospitalWashington D.C.United States100
Childrens of AlabamaBirminghamUnited States2
Cincinnati Childrens Hospital Medical CenterCincinnatiUnited States1
Johns Hopkins UniversityBaltimoreUnited States13
Lurie Children's Hospital of ChicagoChicagoUnited States16
Mayo ClinicRochesterUnited States664
National Cancer Institute/ National Institutes of HealthBethesdaUnited States1
Riley Hospital for Children/Indiana UniversityIndianapolisUnited States2
Stanford UniversityPalo AltoUnited States161
University of ChicagoChicagoUnited States1
University of Texas, SouthwesternDallasUnited States5
Washington University - St. LouisSt LouisUnited States4